Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Skin Neoplasms × Sodium Chloride × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Pain, Postoperative 3 Melanoma 3 Brain Neoplasms 3 Recurrence 2 Ovarian Neoplasms 2 Leukemia, Myeloid, Acute 2 Hemorrhage 2 Chronic Pain 2 Agnosia 2 Vulvodynia 1 Uterine Cervical Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Seizures 1 Radiodermatitis 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Parathyroid Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Pain, Intractable 1

Interventions

Dacarbazine 4 cemiplimab 2 binimetinib 2 Ipilimumab 2 vitespin 1 trametinib 1 tilsotolimod 1 spartalizumab 1 pembrolizumab 1 oblimersen 1 gp100 Melanoma Antigen 1 encorafenib 1 dabrafenib 1 bempegaldesleukin 1 aldesleukin 1 Vinblastine 1 Vemurafenib 1 Tretinoin 1 Standard of Care 1 Sodium Chloride 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Nivolumab 1 Interleukin-2 1 Interferon-alpha 1 Interferon alpha-2 1 Injections 1 Everolimus 1 Educational Status 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00518895 2011-11-07

AGENDA

Genta Incorporated

Phase 3 Completed

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡